메뉴 건너뛰기
Neurocritical Care
Volumn 16, Issue 2, 2012, Pages 299-305
Early ketamine to treat refractory status epilepticus
Author keywords

Hypotension; Ketamine; Sedation; Seizure; Shock; Status epilepticus
Indexed keywords

ANESTHETIC AGENT; CLOBAZAM; ETIRACETAM; KETAMINE; LEVOFLOXACIN; MIDAZOLAM; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NORADRENALIN; PHENYTOIN; PROPOFOL; SEDATIVE AGENT;
EID: 84860886569     PISSN: 15416933     EISSN: 15560961     Source Type: Journal    
DOI: 10.1007/s12028-011-9668-7     Document Type: Article
Times cited : (62)
References (26)
  • 1
    • 80052982365 scopus 로고    scopus 로고
    • Management of refractory status epilepticus in adults: Still more questions than answers
    • Rossetti AO, Lowenstein DH. Management of refractory status epilepticus in adults: still more questions than answers. Lancet Neurol. 2011;10:922-30.
    • (2011) Lancet Neurol. , vol.10 , pp. 922-930
    • Rossetti, A.O.1    Lowenstein, D.H.2
  • 2
    • 0036126003 scopus 로고    scopus 로고
    • Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: A systematic review
    • DOI 10.1046/j.1528-1157.2002.28501.x
    • Claassen J, Hiersch LJ, Emerson RG, Mayer SA. Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review. Epilepsia. 2002;43:146-53. (Pubitemid 34225994)
    • (2002) Epilepsia , vol.43 , Issue.2 , pp. 146-153
    • Claassen, J.1    Hirsch, L.J.2    Emerson, R.G.3    Mayer, S.A.4
  • 4
    • 0033597091 scopus 로고    scopus 로고
    • N-Methyl-D-asparate receptor antagonists abolish the maintenance phase of self-sustaining status epilepticus in rat
    • DOI 10.1016/S0304-3940(99)00238-4, PII S0304394099002384
    • Mazarati AM, Wasterlain CG. N-methyl-D-aspartate receptor antagonists abolish the maintenance phase of self-sustaining status epilepticus in rat. Neurosci Lett. 1999;265:187-90. (Pubitemid 29207397)
    • (1999) Neuroscience Letters , vol.265 , Issue.3 , pp. 187-190
    • Mazarati, A.M.1    Wasterlain, C.G.2
  • 5
    • 0025057211 scopus 로고
    • NMDA receptor activation mediates the loss of GABAergic inhibition induced by recurrent seizures
    • DOI 10.1016/0920-1211(90)90025-Q
    • Kapur J, Lothman EW. NMDA receptor activation mediates the loss of GABAergic inhibition induced by recurrent seizures. Epilepsy Res. 1990;5:103-11. (Pubitemid 20068130)
    • (1990) Epilepsy Research , vol.5 , Issue.2 , pp. 103-111
    • Kapur, J.1    Lothman, E.W.2
  • 6
    • 0033759199 scopus 로고    scopus 로고
    • Ketamine controls prolonged status epilepticus
    • Borris DJ, Bertram EH, Kapur J. Ketamine controls prolonged status epilepticus. Epilepsy Res. 2000;42:117-42.
    • (2000) Epilepsy Res. , vol.42 , pp. 117-142
    • Borris, D.J.1    Bertram, E.H.2    Kapur, J.3
  • 8
    • 0030834935 scopus 로고    scopus 로고
    • Electrographic tachyphylaxis to etomidate and ketamine used for refractory status epilepticus controlled with isoflurane
    • Kofke WA, Bloom MJ, Van Cott A, Brenner RP. Electrographic tachyphylaxis to etomidate and ketamine used for refractory status epilepticus controlled with isoflurane. J Neurosurg Anes-thesiol. 1997;9:269-72. (Pubitemid 27473100)
    • (1997) Journal of Neurosurgical Anesthesiology , vol.9 , Issue.3 , pp. 269-272
    • Kofke, W.A.1    Bloom, M.J.2    Van Cott, A.3    Brenner, R.P.4
  • 9
    • 0031673209 scopus 로고    scopus 로고
    • Refractory status epilepticus: Response to ketamine
    • Sheth RD, Gidal BE. Refractory status epilepticus: response to ketamine. Neurology. 1998;51:1765-6. (Pubitemid 28565277)
    • (1998) Neurology , vol.51 , Issue.6 , pp. 1765-1766
    • Sheth, R.D.1    Gidal, B.E.2
  • 10
    • 4243308883 scopus 로고    scopus 로고
    • The use ofketamine in the treatment of refractory status epilepticus
    • Nathan B, Smith TL, Bleck TB. The use ofketamine in the treatment of refractory status epilepticus. Neurology. 2002;3:A197.
    • (2002) Neurology. , vol.3
    • Nathan, B.1    Smith, T.L.2    Bleck, T.B.3
  • 11
    • 0038070534 scopus 로고    scopus 로고
    • Ketamine for refractory status epilepticus : A case of possible ketamine-induced neurotoxicity
    • DOI 10.1016/S1525-5050(02)00643-1
    • Ubogu EE, Sagar SM, Lerner AJ, et al. Ketamine for refractory status epilepticus: a case of possible ketamine-induced neuro-toxicity. Epilepsy Behav. 2003;4:70-5. (Pubitemid 36546455)
    • (2003) Epilepsy and Behavior , vol.4 , Issue.1 , pp. 70-75
    • Ubogu, E.E.1    Sagar, S.M.2    Lerner, A.J.3    Maddux, B.N.4    Suarez, J.I.5    Werz, M.A.6
  • 12
    • 56449103912 scopus 로고    scopus 로고
    • Ketamine successfully terminates malignant status epilepticus
    • Pruss H, Holtkamp M. Ketamine successfully terminates malignant status epilepticus. Epilepsy Res. 2008;82:219-22.
    • (2008) Epilepsy Res. , vol.82 , pp. 219-222
    • Pruss, H.1    Holtkamp, M.2
  • 13
    • 77953156794 scopus 로고    scopus 로고
    • Terminating prolonged refractory status epilepticus using ketamine
    • Hsieh CY, Sung PS, Tsai JJ, Huang CW. Terminating prolonged refractory status epilepticus using ketamine. Clin Neuropharm. 2010;33:165-7.
    • (2010) Clin Neuropharm. , vol.33 , pp. 165-167
    • Hsieh, C.Y.1    Sung, P.S.2    Tsai, J.J.3    Huang, C.W.4
  • 14
    • 80053568620 scopus 로고    scopus 로고
    • Oral ketamine controlled refractory nonconvulsive status epilepticus in an elderly patient
    • Yeh PS, Shen HN, Chen TY. Oral ketamine controlled refractory nonconvulsive status epilepticus in an elderly patient. Seizure. 2011;20:723-6.
    • (2011) Seizure. , vol.20 , pp. 723-726
    • Yeh, P.S.1    Shen, H.N.2    Chen, T.Y.3
  • 15
    • 78149279161 scopus 로고    scopus 로고
    • Seizure identificationinthe ICU using quantitative EEG displays
    • Stewart CP, OtsuboH,OchiA,etal. Seizure identificationinthe ICU using quantitative EEG displays. Neurology. 2010;75:1501-8.
    • (2010) Neurology. , vol.75 , pp. 1501-1508
    • Stewart, C.P.1    Otsubo, H.2    Ochi, A.3
  • 16
    • 84864796786 scopus 로고    scopus 로고
    • Status epilepticus-induced hyperemia and brain tissue hypoxia after cardiac arrest
    • Ko SB, Ortega-Gutierrez S, Choi HA, et al. Status epilepticus-induced hyperemia and brain tissue hypoxia after cardiac arrest. Arch Neurol. 2011;68:1323-6.
    • (2011) Arch Neurol. , vol.68 , pp. 1323-1326
    • Ko, S.B.1    Ortega-Gutierrez, S.2    Choi, H.A.3
  • 17
    • 0039698147 scopus 로고    scopus 로고
    • Ketamine prevents learning impairment when administered immediately after status epilepticus onset
    • DOI 10.1006/ebeh.2001.0272, PII S1525505001902720
    • Stewart LS, Persinger MA. Ketamine prevents learning impairment when administered immediately after status epilepticus onset. Epilepsy Behav. 2001;2:585-91. (Pubitemid 33586218)
    • (2001) Epilepsy and Behavior , vol.2 , Issue.6 , pp. 585-591
    • Stewart, L.S.1    Persinger, M.A.2
  • 18
    • 38649086112 scopus 로고    scopus 로고
    • A combination of ketamine and diazepam synergistically controls refractory status epilepticus induced by cholinergic stimulation
    • DOI 10.1111/j.1528-1167.2007.01384.x
    • Martin BS, Kapur J. A combination of ketamine and diazepam synergistically controls refractory status epilepticus induced by cholinergic stimulation. Epilepsia. 2008;49:248-55. (Pubitemid 351171997)
    • (2008) Epilepsia , vol.49 , Issue.2 , pp. 248-255
    • Martin, B.S.1    Kapur, J.2
  • 19
    • 73349137319 scopus 로고    scopus 로고
    • Propofol infusion syndrome in patients with refractory status epilepticus: An 11-year clinical experience
    • Iyer VN, Hoel R, Rabinstein AA. Propofol infusion syndrome in patients with refractory status epilepticus: an 11-year clinical experience. Crit Care Med. 2009;37:3024-30.
    • (2009) Crit Care Med. , vol.37 , pp. 3024-3030
    • Iyer, V.N.1    Hoel, R.2    Rabinstein, A.A.3
  • 20
  • 21
    • 0141789591 scopus 로고    scopus 로고
    • The pathophysiology of propofol infusion syndrome: A simple name for a complex syndrome
    • DOI 10.1007/s00134-003-1905-x
    • Vasile B, Rasulo F, Candiani A, Latronico N. The pathophysi-ology of propofol infusion syndrome: a simple name for a complex syndrome. Intensive Care Med. 2003;29:1417-25. (Pubitemid 37153585)
    • (2003) Intensive Care Medicine , vol.29 , Issue.9 , pp. 1417-1425
    • Vasile, B.1    Rasulo, F.2    Candiani, A.3    Latronico, N.4
  • 22
    • 0141493917 scopus 로고    scopus 로고
    • Oral ketamine in paediatric non-convulsive status epilepticus
    • DOI 10.1016/S1059-1311(03)00028-1
    • Mewasingh LD, Skhara T, Aeby A, et al. Oral ketamine in pae-diatric non-convulsive status epilepticus. Seizure. 2003;12:483-9. (Pubitemid 37168637)
    • (2003) Seizure , vol.12 , Issue.7 , pp. 483-489
    • Mewasingh, L.D.1    Sekhara, T.2    Aeby, A.3    Christiaens, F.J.C.4    Dan, B.5
  • 24
    • 0034688312 scopus 로고    scopus 로고
    • Glutamate release in severe brain ischaemia is mainly by reversed uptake
    • DOI 10.1038/35002090
    • Rossi DJ, Oshima T, Attwell D. Glutamate release in severe brain ischaemia is mainly be reversed uptake. Nature. 2000;403:316-21. (Pubitemid 30062388)
    • (2000) Nature , vol.403 , Issue.6767 , pp. 316-321
    • Rossi, D.J.1    Oshima, T.2    Attwell, D.3
  • 25
    • 55549135314 scopus 로고    scopus 로고
    • Anti-NMDA-receptor encephalitis: Case series and analysis of the effects of antibodies
    • Dalmau J, Gleichman AJ, Hughes EG, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. 2008;7:1091-8.
    • (2008) Lancet Neurol. , vol.7 , pp. 1091-1098
    • Dalmau, J.1    Gleichman, A.J.2    Hughes, E.G.3
  • 26
    • 79957525471 scopus 로고    scopus 로고
    • NMDA receptors: Recent insights and clinical correlations
    • Benarroch EE. NMDA receptors: recent insights and clinical correlations. Neurology. 2011;76:1750-7.
    • (2011) Neurology. , vol.76 , pp. 1750-1757
    • Benarroch, E.E.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.